Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M12,517Revenue (TTM) $M14,563Net Margin (%)4.9Altman Z-Score2.1
Enterprise Value $M20,277EPS (TTM) $3.5Operating Margin %12.1Piotroski F-Score7
P/E(ttm)18.3Beneish M-Score-2.7Pre-tax Margin (%)9.3Higher ROA y-yY
Price/Book2.610-y EBITDA Growth Rate %11.7Quick Ratio1.5Cash flow > EarningsY
Price/Sales0.95-y EBITDA Growth Rate %9.4Current Ratio1.6Lower Leverage y-yY
Price/Free Cash Flow12.1y-y EBITDA Growth Rate %30.4ROA % (ttm)3.8Higher Current Ratio y-yN
Dividend Yield %--PEG1.9ROE % (ttm)14.8Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M197ROIC % (ttm)8.7Gross Margin Increase y-yN

Gurus Latest Trades with DVA

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
DVAArnold Van Den Berg 2016-12-31 Sold Out -0.82%$55.16 - $66.59
($62.28)
$ 63.121%Sold Out0
DVAJoel Greenblatt 2016-09-30 Buy 0.04%$63.34 - $78.44
($70.4)
$ 63.12-10%New holding45,595
DVAArnold Van Den Berg 2016-09-30 Reduce-0.03%$63.34 - $78.44
($70.4)
$ 63.12-10%Reduce -2.54%77,285
DVAMario Gabelli 2016-09-30 Reduce$63.34 - $78.44
($70.4)
$ 63.12-10%Reduce -19.20%32,613
DVAArnold Van Den Berg 2016-06-30 Reduce-3.14%$73.03 - $77.93
($75.54)
$ 63.12-16%Reduce -75.89%79,300
DVAJoel Greenblatt 2016-06-30 Sold Out -0.42%$73.03 - $77.93
($75.54)
$ 63.12-16%Sold Out0
DVAMario Gabelli 2016-06-30 Reduce$73.03 - $77.93
($75.54)
$ 63.12-16%Reduce -2.89%40,363
DVAArnold Van Den Berg 2016-03-31 Add0.76%$62.24 - $73.38
($67.47)
$ 63.12-6%Add 22.67%328,908
DVAJoel Greenblatt 2016-03-31 Add0.17%$62.24 - $73.38
($67.47)
$ 63.12-6%Add 69.62%513,100
DVAMario Gabelli 2016-03-31 Add$62.24 - $73.38
($67.47)
$ 63.12-6%Add 4.00%41,563
DVASteve Mandel 2015-12-31 Sold Out -2.41%$67.79 - $78.16
($73.23)
$ 63.12-14%Sold Out0
DVAArnold Van Den Berg 2015-12-31 Reduce-0.22%$67.79 - $78.16
($73.27)
$ 63.12-14%Reduce -6.22%268,133
DVAJoel Greenblatt 2015-12-31 Add0.19%$67.79 - $78.16
($73.23)
$ 63.12-14%Add 525.25%302,502
DVAMario Gabelli 2015-12-31 Reduce$67.79 - $78.16
($73.23)
$ 63.12-14%Reduce -4.31%39,963
DVAArnold Van Den Berg 2015-09-30 Add1.63%$70.93 - $81.14
($77.54)
$ 63.12-19%Add 85.75%285,918
DVASteve Mandel 2015-09-30 Add0.75%$70.93 - $81.14
($77.54)
$ 63.12-19%Add 45.15%7,918,998
DVAJoel Greenblatt 2015-09-30 Buy 0.03%$70.93 - $81.14
($77.54)
$ 63.12-19%New holding48,381
DVAArnold Van Den Berg 2015-06-30 Reduce-0.11%$79.47 - $84.23
($82.11)
$ 63.12-23%Reduce -5.86%153,928
DVAMario Gabelli 2015-06-30 Add$79.47 - $84.23
($82.11)
$ 63.12-23%Add 5.29%41,763
DVAArnold Van Den Berg 2015-03-31 Buy 1.87%$72.78 - $82.84
($76.74)
$ 63.12-18%New holding163,503
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

DVA is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


DVA: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
STAFFIERI MICHAEL DAVIDCOO, Kidney Care 2016-08-09Sell20,262$73.09-13.64view
JIGANTI JEANINE MARIEChief Compliance Officer 2016-07-11Sell1,291$78.51-19.6view
JIGANTI JEANINE MARIEChief Compliance Officer 2016-07-01Sell4,620$77.45-18.5view
Arway Pamela MDirector 2016-05-25Sell10,824$77.16-18.2view
HILGER JAMES KInterim CFO and CAO 2016-05-23Sell3,416$76.79-17.8view
THIRY KENT JChairman and CEO 2016-05-20Sell32,880$76.99-18.02view
Kogod DennisPres, HCP & CEO, DVA Int. 2016-05-17Sell17,700$77.35-18.4view
ZUMWALT LEANNE MGrp VP, Purch & Public Affairs 2016-05-17Sell538$77.08-18.11view
HILGER JAMES KInterim CFO and CAO 2016-05-16Sell3,983$75.59-16.5view
STAFFIERI MICHAEL DAVIDCOO, Kidney Care 2016-05-16Sell4,934$75.69-16.61view

Press Releases about DVA :

Quarterly/Annual Reports about DVA:

News about DVA:

Articles On GuruFocus.com
Another Attempt to Trumpet a Mistake Dec 19 2016 
Are Any of Buffett's Holdings Cheap Enough to Buy? Nov 09 2016 
3 Warren Buffett Stocks Fall to 52-Week Lows Oct 28 2016 
Baxter Well Positioned in Fast-Growing Market for Kidney Dialysis Equipment Jul 01 2016 
Arnold Van Den Berg's Largest Buys in 1st Quarter Apr 21 2016 
Weekly CEO Sells Highlights Apr 18 2016 
7 High Quality Guru Stocks Apr 11 2016 
Steve Mandel Sells Health Care Stakes Mar 11 2016 
Undervalued, Predictable Companies Include Monsanto and Western Union Mar 10 2016 
Alan Fournier Makes Modest Reductions in Middleby and Priceline Jan 12 2016 

More From Other Websites
DaVita, Inc. – Value Analysis (NYSE:DVA) : January 23, 2017 Jan 23 2017
DaVita, Inc. breached its 50 day moving average in a Bearish Manner : DVA-US : January 20, 2017 Jan 20 2017
Lifshitz & Miller Law Firm Announces Investigation of DaVita Inc., First NBC Bank Holdings Company,... Jan 18 2017
[$$] Judge Blocks Rule That Could Limit Premium Assistance for Dialysis Patients Jan 12 2017
U.S. judge blocks rule on financial assistance for dialysis patients Jan 12 2017
IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Investigation of DaVita Inc. and Advises... Jan 12 2017
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DaVita Inc. -... Jan 10 2017
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Violations... Jan 10 2017
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of DaVita Inc. (DVA) Jan 10 2017
Amgen Inks Multiple Deals, Offers Update on Repatha Lawsuit Jan 10 2017
DAVITA NOTIFICATION: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of... Jan 09 2017
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against DaVita Inc. - DVA Jan 09 2017
DaVita Inc. to Present at the 35th Annual J.P. Morgan Healthcare Conference Jan 09 2017
DAVITA INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a... Jan 09 2017
DaVita Enters Into New Sourcing and Supply Agreement with Amgen and Initiates 2017 Kidney Care... Jan 09 2017
European shares slip, FTSE 100 at record high Jan 09 2017
Dialysis Providers Fall After Disclosing Patient-Care Subpoenas Jan 09 2017
Fresenius Medical, DaVita subpoenaed over premium assistance Jan 07 2017
[$$] Justice Department Probing Premium Assistance for Dialysis Patients Jan 06 2017
[$$] Justice Department Probing Premium Assistance for Dialysis Patients Jan 06 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)